Vancomycin and ototoxicity

vancomycin in terms of the volume of distribution and the rate of drug clearance from plasma.1. The risk of ototoxicity and nephrotoxicity from vancomycin

by LP Rybak 2024 Cited by 35ototoxicity, clarithromycin ototoxicity, macrolide ototoxicity, vancomycin ototoxicity and chloramphenicol ototoxicity. furosemide), but this

to be augmented by vancomycin.8 None of the cases is a clear, unambigu- ous example of vancomycin ototoxicity. Kirby and associates31 in 2024, reported one case of ototoxicity among 33 patients treated with vancomycin. The patient with ototoxicity had received neomycin previously for more than a month before receiving the

This article details clinical reports and animal studies of ototoxicity associated with vancomycin and its analogues. From these studies, the ototoxicity of these agents is still not clear. In the author's opinion, vancomycin must affect the auditory system in a manner that results in augmentation of the usual ototoxicity of aminoglycoside antibiotics. This postulated effect may manifest as a

inhibited; aminophylline converted to theophylline). CLOSE. amphotericin VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity; VANCOMYCIN PO

by YY Grabie 2024 Cited by 1Keywords: mixed hearing loss, sepsis treatment, severe sepsis, sensorinerual hearing loss, oral vancomycin vancomycin-induced ototoxicity by

Ototoxicity is a rare complication associated with vancomycin monotherapy. It is common in patients receiving excessive vancomycin doses, concurrent ototoxic medications (e.g, aminoglycosides, loop diuretics, antineoplastic agents), and those with underlying hearing loss conditions.

Amiodarone. Tetracycline. Fluoroquinolones. Rash (Stevens-Johnson Nephrotoxicity/ototoxicity. Aminoglycosides (neomycin). Vancomycin.

Effect of N - acetylcysteine in the prevention of ototoxicity caused by vancomycin in the treatment of peritonitis in patients undergoing peritoneal dialysis.